🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The aim of the present work is to evaluate the efficacy and safety of diphe...
Status
Completed
Location
University hospitals faculty of medicine ain shams university
Start Date
2021-01-17
Trial ID
NCT04775979
Treatments Being Tested
Ultraviolet (UV) light is part of normal sunlight and has many effects on h...
Status
Completed
Location
Innovaderm Research Inc.
Start Date
2013-11
Trial ID
NCT01978483
Treatments Being Tested
Melanoma is a life-threatening cancer which poses a significant health burd...
Status
Completed
Location
The Rockefeller University
Start Date
2012-10-16
Trial ID
NCT01711684
Treatments Being Tested
The overall goal of this study is to determine novel mechanisms for ultravi...
Status
Active Not Recruiting
Location
Whitaker Clinic
Start Date
2022-03-21
Trial ID
NCT05020496
Treatments Being Tested
This is an open labeled study to determine the response and characteristics...
Status
Terminated
Location
University of Minnesota Department of Dermatology
Start Date
2024-04-01
Trial ID
NCT03651752
Treatments Being Tested
This study will be conducted in 2 cohorts. In Cohort A, approximately 40 s...
Status
Completed
Location
Innovaderm Research Inc.
Start Date
2018-07-26
Trial ID
NCT03625219
Treatments Being Tested
This is a phase I, open label study employing diphencyprone (DPCP) to chara...
Status
Recruiting
Location
Icahn School of Medicine at Mount Sinai
Start Date
2022-10-06
Trial ID
NCT05481658
Treatments Being Tested
The drug diphenylcyclopropenone, or DPCP, modifies the immune system and ha...
Status
Completed
Location
The Rockefeller University
Start Date
2011-10
Trial ID
NCT01452594
Treatments Being Tested
This two cohort study (Cohort A and B) is being conducted to assess the saf...
Status
Completed
Location
Innovaderm Research Inc.
Start Date
2017-03-14
Trial ID
NCT03089775
Treatments Being Tested
Neurofibromatosis type 1 (NF1) is the most common genetic tumor predisposit...
Status
Completed
Location
Icahn School of Medicine at Mount Sinai
Start Date
2022-09-14
Trial ID
NCT05438290
Treatments Being Tested